The Efficacy and Tolerability of Pegylated Interferon-α-2a in Chronic Hepatitis B: A Multicenter Clinical Experience

Journal of Gastroenterology and Hepatology, 04/26/2012

In everyday clinical practice Pegylated Interferon–α (PEG–IFN) therapy in chronic Hepatitis B (CHB) is well tolerated and can achieve a similar efficacy to that seen in large controlled trials.

Print Article Summary Cat 2 CME Report